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This study reports on the use of a new sensitive assay of CAMP-dependent protein kinase activity to examine the effect of cholecystokinin (CCK) 
on the CAMP second messenger cascade in rat pancreatic acini. Treatment of acini with both low (PM) and high (nM) concentrations of CCK 
was associated with an increase in CAMP-dependent protein kinase activity. The increases in kinase activity were detected in the absence of 
phosphodiesterase inhibition, a condition required to detect a measurable increase in cellular CAMP in these cells. Furthe~ore, the CAMP cascade 
was dissociated from the secretory effects of CCK, since the CCK analogue, OPE, mediates enzyme secretion but does not increase celluiar CAMP 
levels or kinase activity. 
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1. INTRODUCTION 
The effects of hormoneereceptor interaction on the 
production of Ca’+, inositol phosphate, or cyclic nucle- 
otide second messengers has been extensively studied. 
In contrast, little is known about the subsequent cou- 
pling of these pathways to protein kinase activation. 
The complexity of interaction among different signal 
transduction pathways makes it difficult to quantita- 
tively relate the generation of a particular intracellular 
signal to the activation of its effector kinase. 
In this study, the relationship between CAMP and the 
activation of its physiologic effector, CAMP-dependent 
protein kinase, has been examined in rat pancreatic 
acini following stimulation with cholecystokinin 
(CCK). This system was chosen because it has served 
as a paradigm for the study of both CCK-regulated 
zymogen secretion and, most recently, intracellular pro- 
teolysis. The role of CCK in this system, however, is 
quite complex. Based on receptor binding assays, the 
pancreatic acinar cell exhibits at least two affinity states 
of the CCK receptor which are functionally coupled to 
different cellular responses. To better define the cellular 
mechanisms of CCK action, CCK analogues such as 
OPE have been developed that stimulate only a subset 
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of the biological effects of CCK [I]. Two groups of 
biological responses to CCK receptor agonists have 
been observed. Low concentrations of CCK and OPE 
stimulate zymogen secretion while other effects, such as 
the inhibition of secretion and the stimulation of intra- 
cellular zymogen proteolysis, result only from stimula- 
tion by high concentrations of native CCK. The second 
messenger pathways that mediate these responses have 
not been fully defined. Although most efforts have fo- 
cused on the role of the Ca” signalling pathway in the 
mediation of zymogen secretion, the role of the CAMP 
pathway in mediating some of the effects of CCK has 
not been well studied. 
The present study describes a sensitive assay for 
CAMP-dependent protein kinase activity in pancreatic 
acini. This method has been used to directly examine the 
effect of CCK and OPE on the activity of CAMP-de- 
pendent protein kinase in rat pancreatic acini. In this 
system, we find that CCK activates CAMP-dependent 
protein kinase while OPE does not, apparently dissoci- 
ating this activation from the secretory cascade. In addi- 
tion, we find that the measurement of CAMP levels did 
not always correlate with total CAMP-dependent pro- 
tein kinase activity in these cells. 
2. MATERIALS AND METHODS 
Isolated pancreatic acini were prepared from fasted male Sprague-- 
Dawley rats by collagenase digestion and mechanical disruption as 
described [2]. Crude type 3 collagenase (Worthington Biochemical 
Co., Freehold, NJ) was purified by gel filtration chromatography 
prior to use [3]. 
Acini (90 ,H), suspended in oxygenated medium A (98 mM NaCl, 
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4.8 mM KCI, 2.5 mM KH,PO,, 2 mM CaCl,, 1.2 mM MgCl,, 0.2% 
BSA, 0.05% DTT, and 25 mM HEPES, pH 7.4) were equilibrated at 
37°C prior to stimulation. Acinar suspensions used throughout this 
study contained -3 mg protein/ml. 
Hormonal stimulation of acini utilized cholecystokinin octapeptide 
(CCK) from Squibb Diagnostics, New Brunswick, NJ and D-Tyr-Gly- 
[(NleZ8~3’)CCK-26-32J-phenethyl ester (OPE) [l]. Unstimulated (US) 
samples received an equivalent volume of medium alone. All secre- 
tagogue treatments were performed at 37°C under 100% oxygen in 100 
PI final volumes. 
Acinar homogenates were prepared, following secretagogue treat- 
ment, by adding 100 ~1 of ice cold medium B (100 mM NaCI, 20 mM 
Na pyrophosphate, 2 mM EDTA, 3 mM EGTA, and 25 mM HEPES, 
pH 7.4 containing 2.5 mg/ml of STI, 0.1 mM PMSF, and 1 mg/ml each 
of leupeptin, chymostatin, pepstatin, and aprotinin) to the acinar 
suspensions. The cells were then disrupted by 8 passes through a 
30-gauge needle. Samples were centrifuged at 4°C at 1800 x g for 2 
min and the supematants, comprised almost exclusively of small mem- 
brane vesicles suspended in cytosol, were assayed for A-kinase activ- 
ity. 
CAMP-dependent protein kinase activity was assayed in vitro by 
measuring the CAMP-dependent protein kinase site-specific phospho- 
rylation of an exogenous substrate, synapsin 1 [4,5], provided by A. 
Czernik, Rockefeller University, New York. In vitro phosphorylation 
of the synapsin 1 by endogenous acinar cell CAMP-dependent protein 
kinase was performed under calcium-free conditions with 50 mM 
HEPES, pH 7.4, 10 mM MgCl,, 1 mM EGTA, 20 mM ATP contain- 
ing 0.1 mCi/ml [y-“P]ATP (DuPont~EN, Boston, MA), 0.01 mgiml 
synapsin I, and -0.3 mgiml of acinar supernatant protein [6]. Phos- 
phorylation reactions, performed for 2 min at 30°C were terminated 
by adding 50 ~1 of boiling 3x Laemmli sample buffer. 
The in vitro phosphorylated synapsin 1 was separated from other 
acinar proteins by SDS-PAGE [7] and identified by autoradiography. 
Total synapsin counts per minute (cpm) of 32P incorporated into the 
synapsin 1 bands were determined by Chrenkov counting. To quanti- 
tate the CAMP-dependent protein kinase component of total synapsin 
phosphorylation, the synapsin 1 band was excised and subjected to 
one-dimensional peptide mapping using Staphylococcus aureus V-8 
protease (Boehringer Mannheim, Indianapolis, IN) as described [8]. 
Fig. la shows the V-8 phosphopeptide maps of synapsin 1 phosphoryl- 
ation by homogenates from unstimulated acini. As reported [4], V-8 
protease cleaves phosphorylated synapsin 1 into two phosphopeptides 
(32 kDa and 10 kDa). Phosphorylation of the 32 kDa peptide, which 
contains the synapsin 1 phospho~lation site for Ca*+/calmodulin- 
dependent protein kinase II, is enhanced by the addition of Ca” and 
calmodulin (lane 2). The addition of CAMP (lane 3) markedly en- 
hances the phosphorylation of the 10 kDa peptide, which contains the 
synapsin 1 phosphorylation site for CAMP-dependent protein kinase. 
Although a small amount of Ca*‘-dependent phosphorylation of the 
10 kDa peptide, presumably by ~*+/calmodulin-dependent protein 
kinase I, can be appreciated in lane 2, the assays performed in lane 3 
and throughout the remainder of this study were performed under 
Ca”-free conditions. Addition of the selective CAMP-dependent pro- 
tein kinase inhibitor H-89 [9], supplied by H. Hidaka. Nagoya Univer- 
sity, Nagoya, Japan, blocked the Ca”-independent phosphorylation 
of the 10 kDa peptide (Fig. lb). This finding supports the conclusion 
that phosphorylation of this lower MW peptide under Ca”-free con- 
ditions represent the activity of CAMP-dependent protein kinase. In 
the current study, relative activity of the kinase in stimulated acini was 
normalized to that present in unstimulated controls. 
Measurement of CAMP levels from rat pancreatic acini were deter- 
mined using a competitive radio-binding assay (Diagnostic Products 
Corporation, Torrence, CA). In these studies, -400 mg of acinar cell 
protein was used for each determination. Some acini were pre-incu- 
bated for 15 min with 1 mM 3-isobutyl-l-methylxanthene (IBMX), 
from Aldrich Chemical Company, Milwauk~, WI, before treatment 
with secretagogue or medium. 
Statistical analysis was applied to each experimental condition 
which was run in triplicate and expressed as the mean f one SE. of 
the triplicates. In some determinations (Figs. 4 and 5), triplicates from 
replicate experiments were combined for data analysis. Statistical 
probability was dete~ined by the unpaired (-test. 
3. RESULTS 
3.1. CAMP production 
It has been well established in the literature that CCK 
does not produce a detectable increase in cellular CAMP 
levels in isolated pancreatic acini unless the acini are 
pretreated with a phosphodiesterase inhibitor [lo---143. 
Furthermore, in the presence of phosphodiesterase inhi- 
bition, a rise in CAMP levels can only be detected fol- 
lowing stimulation by high (nM) concentrations of 
CCK. Studies in our laboratory confirm those findings 
(Fig. 2), demonstrating that rises in CAMP are detected 
only in IBMX pre-treated acini stimulated with high 
(greater than 10e9 M) concentrations of CCK. 
To establish that this high-dose CCK effect is recep- 
tor mediated, the effect of the OPE analogue of CCK 
on CAMP production was examined. OPE competitively 
binds to the CCK receptor, stimulates enzyme secretion, 
and partially blocks the inhibition of enzyme secretion 
caused by high-dose CCK [l]. As demonstrated in Fig. 
2, OPE is unable to raise cellular CAMP levels in IBMX 
pre-treated acini. Furthe~ore, 1 mM OPE partially 
blocks the accumulation of CAMP induced by high 
(nM) concentrations of CCK. These findings demon- 
strate that CAMP production by CCK results from a 
CCK receptor-mediated pathway that is not activated 
by OPE. 
3.2. CAMP dependent protein kinase activity 
Using the synapsin 1 phosphorylation assay system, 
the effect of CCK on the activation of CAMP-dependent 
protein kinase in rat pancreatic acini was examined. 
Initial studies were performed in acini that had not been 
pre-treated with IBMX (i.e. under conditions which do 
not increase cellular CAMP to measurable levels). Fig. 
3 shows a representative concentration-dependence 
curve for CCK and CAMP-dependent protein kinase 
activity. Compared to unstimulated controls, a relative 
increase in CAMP-dependent protein kinase activity is 
most readily apparent following treatment with high 
(nM) concentrations of CCK. The OPE analogue of 
CCK, whether used in low or high concentrations, does 
not increase kinase activity. 
The temporal relationship between high-dose CCK, 
CAMP, and CAMP-dependent protein kinase activity 
was next examined (Fig. 4). Based on the concentration 
dependence curve in Fig. 3, low7 M CCK was chosen as 
the high concentration of CCK to be studied in greater 
detail. In acini not pre-treated with IBMX, CAMP-de- 
pendent protein kinase activity rose rapidly following 
exposure to lo-’ M CCK, peaked within 10 min, and 
remained above background levels for exposures as 
long as 30 min (closed squares, Fig. 4a). This figure is 
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Fig. 1. Autoradiograph of in vitro phosphorylated synapsin 1 following digestion with ~~~~~~~~eor~~{.~ aweus V-8 protease. Rat pancreatic acini 
were treated with IO-’ M CCK (CCK) or medium alone (US) for 10 min. Synapsin 1 phosphorylation and V-8 protease peptide mapping was then 
performed as described in section 2. (a) Effect of kinasc cofactor additions on the site-specific phosphorylation of synapsin 1 in vitro. Basal kinase 
activity in the post-nuclear supernatant of unstimulated acinar cells is shown in the left panel (US). Effect of adding 1.5 mM CaClz (Ca) or 10 mM 
CAMP (CAMP) on the in vitro phosphorylation of synapsin 1 is shown in the subsequent panels. (b) Effect of 10 mM H-89 on the site-specific 
phosphoryl~~tioil of synapsin I by acini treated with-IO_’ M CCK. 
representative of the pattern of CAMP-dependent pro- 
tein kinase activation by high-dose CCK. Replicate de- 
terminations at the 5-min time point (8 separate experi- 
ments, each run in triplicate) have demonstrated that 
IV7 M CCK increases CAM-dependent protein kinase 
activity to 1.58 times that of unstimulated controls (SE. 
= 0.04, P < 0.001 compared to controls). Pre-treatment 
d 
/if CCK + 10~‘MOPE 
00 
-10 9 -8 7 6 
log [peptide] 
Fig. 2. Dose effect of CCK and OPE on CAMP levels in acini pre- 
treated with I mM IBMX. Closed circles, CCK alone. Open circles, 
OPE alone. Crossed circles, CCK dose-response in the presence of 10.’ 
M OPE. Acini were treated with secretagogues for IO min. Results are 
expressed as the mean 2 one S.E. of each condition run in triplicate 
from a representative experiment. 
of acini with IBMX, which raises total cellular CAMP 
to detectable levels, increased the magnitude of kinase 
activation by high-dose CCK without appreciably alter- 
ing the time course of activation (open squares, Fig. 4a). 
To further characterize the relationship between CAMP 
I I I I I I I 1 
-12 -11 -10 -9 -8 -7 -6 
log [peptide] 
Fig. 3. Dose effect of CCK-8 and OPE on A-kinase activity in acini 
not pretreated with IBMX. Acini were treated with secretagogues for 
IO min. Results are expressed as the mean i one S.E. ofeach condition 
run in triplicate from a representative experiment. 
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Fig. 4. Time course of activation of the CAMP pathway by 10e7 M CCK. (A) Effect of IBMX on A-kinase activation. Closed squares, no IBMX 
pretreatment. Crossed squares, acini pretreated for 15 min with 1 mM IBMX. Analysis of 8 separate experiments demonstrates a significant increase 
in A-kinase activity over the unstimulated control at the T= 5 min time point (P < 0.001). (B) Relationship between CAMP levels and A-kinase 
activation in IBMX pretreated acini. Results are expressed as the mean 2 one S.E. of each condition run in triplicate from a representative 
experiment. 
and CAMP-dependent protein kinase activity, the tem- 
poral relationship between CAMP and its effector kinase 
was examined in IBMX-pretreated acini (Fig. 4b). At 
early time points, kinase activity closely followed the 
rise in cellular CAMP. At later time points, kinase activ- 
ity closely followed the rise in cellular CAMP. At later 
time points, however, kinase activity decreased while 
CAMP levels continued to rise. 
Finally, the effect of a low dose of CCK on CAMP- 
dependent protein kinase activity was examined. In our 
laboratory, 5 x IO-r0 M CCK maximally stimulates am- 
ylase release in rat pancreatic acini. This concentration 
of CCK, however, does not increase CAMP to measura- 
ble levels, even in the presence of phosphodiesterase 
inhibition. Fig. 5 shows the time course of CAMP-de- 
pendent protein kinase activation by 5 x lo-” M CCK 
in acini not exposed to IBMX. A small but statistically 
significant 24% increase in kinase activity is detected 5 
min after treatment with this low concentration of CCK 
(for 7 separate experiments, each time point run in trip- 
licate, the relative activity = 1.24 rt 0.045 S.E., P < 0.01). 
This increase in kinase activity was of lesser magnitude 
and of shorter duration than that seen following high- 
dose CCK treatment. Furthermore, this low-dose re- 
sponse occurred under conditions which do not ellicit 
a measurable increase in cellular CAMP levels [lo-121, 
even in acini pre-treated with IBMX (data not shown). 
4. DISCUSSION 
In this study, we have described a sensitive method 
for assaying CAMP-dependent protein kinase activity in 
rat pancreatic acini. There are two reasons for develop- 
ing this assay. First, physiologically significant changes 
in CAMP may be below the level of detection by cur- 
rently available CAMP assay systems [12,15--- 1’71. Sec- 
ond, the mechanism for the activation of some protein 
kinases has the potential to generate an enzymatic activ- 
ity that persists even after second messenger levels de- 
crease [6]. The assay used in this study takes advantage 
of the fact that the activation of kinase by CAMP results 
in the dissociation of the regulatory subunits from the 
holoenzyme, resulting in the liberation of cofactor-inde- 
pendent catalytic subunits. Thus, the activation of 
CAMP-dependent protein kinase following neurohu- 
moral stimulation of intact cells can be subsequently 
determined by measuring in vitro the activity of its 
cofactor-independent catalytic subunit. Under the cal- 
cium-free conditions employed in this study, the in vitro 
phosphorylation on a specific region of synapsin 1 
served as a specific assay for determining relative 
LAMP-dependent protein kinase activity. Although 
synapsin 1 was used as a substrate, it is likely that other 
CAMP-dependent protein kinase substrates may be 
utilized in similar assay systems. Furthermore, the 
methodology described in this study may be applicable 
to other dispersed cell systems in which the direct meas- 
urement of neurohumorally-stimulated CAMP-depend- 
ent protein kinase activity is desired. 
Although it has been known that high concentrations 
of CCK can increase cellular CAMP levels in acini if 
they are pre-treated with IBMX [lo-121, the effect of 
CCK treatment on CAMP-dependent protein kinase ac- 
tivity has not been previously examined. By measuring 
kinase activity directly, the current study was able to 
establish that CAMP-dependent protein kinase is acti- 
vated by CCK in rat pancreatic acini over a broad range 
of concentrations and that this activation occurs in the 
absence of IBMB pre-treatment or a detectable increase 
in cellular CAMP. There are several potential explana- 
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Fig. 5. Time-course of A-kinase activation by 5 x 1 O-” M CCK in acini 
not pretreated with IBMX. The data points represent the means i one 
SE. from 6 separate experiments, within which each time point was 
run in triplicate. Relative to the T= 0 min and T= 30 mitt time points, 
a significant increase in A-kinase activation is noted at 5 min 
(P < 0.001 for each comparison) and 10 min (P < 0.01 for each 
comparison). 
tions for this dissociation between second messenger 
levels and kinase activity. First, it is possible that the 
current methods for measuring CAMP are not sensitive 
enough to detect physioIogically significant elevations 
in this intracellular signal. This possibility is supported 
by the data in Fig. 4a, which correlates the magnitude 
of early kinase activation with the amplification of a 
CAMP signal by IBMX. Thus, the activation of a small, 
yet functionally significant, pool of CAMP within the 
cell may go undetected when measuring total cellular 
CAMP levels. Secondly, it is possible that an increase in 
the metabolic cycling of CAMP (which is revealed under 
conditions of phosphodiester~se inhibition) is capable 
of activating this enzyme in the absence of a measurable 
increase in the total cellular level of CAMP. Such a 
metabolic cycling of CAMP has been reported to medi- 
ate early amylase secretion in the rat parotid gland [ 181. 
Thirdly, since this assay measures net substrate phos- 
phorylation, it is possible that mechanisms independent 
of CAMP-dependent protein kinase activity may influ- 
ence total substrate phosphorylation. For example, 
CCK stimulation may indirectly increase net kinase ac- 
tivity by directly inhibiting an opposing phosphatase 
activity. Irrespective of the mechanism, the data pre- 
sented in this study demonstrates that the absence of a 
measurable increase in cellular CAMP in response to 
secretagogues cannot be used to exclude a role for 
CAMP-dependent protein kinase in the effect of that 
secretagogue. 
Another conclusion to be drawn from this study is 
that a dissociation can be made between CCK-induced 
enzyme secretion and the activation of CAMP-depend- 
ent protein kinase. This is illustrated by the OPE data, 
which demonstrates that this fully efficacious secre- 
tagogue, acting through occupation of the CCK recep- 
tor, does not activate CAMP-dependent protein kinase. 
Thus, enzyme secretion by CCK appears to be inde- 
pendent of the hormone’s effect on CAMP-dependent 
protein kinase activity. Based on CCK dose-response 
data from this and other studies [12,19], it is tempting 
to speculate that CAMP-dependent protein kinase acti- 
vation by CCK may be involved in the inhibition of 
secretion and/or the intracellular activation of zymo- 
gens. 
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